Eli Lilly pharmaceutical company to cut insulin prices, cap costs at $35 for many with diabetes

On Wednesday, CEO of pharmaceutical company Eli Lilly announced a series of price cuts that would lower the price of the most commonly used forms of its insulin 70% and said it will automatically cap out-of-pocket insulin costs at $35 for people who have private insurance and use participating pharmacies.